Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

Hilma J. Van der Horst, A. Vera de Jonge, Ida H. Hiemstra, Anne T. Gelderloos, Daniella Rai Berry, Nathalie J. Hijmering, Daphne de Jong, Martine E. D. Chamuleau, Sonja Zweegman, Esther C. W. Breij, Margaretha G. M. Roemer, Tuna Mutis

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalBlood
Volume134
DOIs
Publication statusPublished - 13 Nov 2019

Cite this